|
|
|
|
Publications 2004
|
- Aandahl EM, Michaelson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454–2459, 2004.
- Aandahl EM, Quigley MF, Moretto WJ, Moll M, Gonzalez VD, Sönnerborg A, Lindbäck S, Hecht FM, Deeks SG, Rosenberg MG, Nixon DF, Sandberg JK. Expansion of CD7low and CD7negative CD8 T-cell effector subsets in HIV-1 infection: Correlation with antigenic load and reversion by antiretroviral treatment. Blood 104:3672–3678, 2004.
- Angel JB, Hu YW, Kravcik S, Tsui R, Lee KH, Barbour J, Balaskas E, Branson BM, Delwart EL, Grant RM. Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection. AIDS 18:331–334, 2004.
- Barbour JD, Hecht FM, Wrin T, Segal MR, Ramstead CA, Liegler TJ, Busch MP, Petropoulos CJ, Hellmann NS, Kahn JO, Grant RM. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection. J. Infect. Dis. 190:251–256, 2004.
- Barbour JD, Grant RM. The clinical implications of reduced viral fitness. Curr. Infect. Dis. Rep. 6:151–158, 2004.
- Barbour JD, Hecht FM, Wrin T, Liegler TJ, Ramstead CA, Busch MP, Segal MR, Petropoulos CJ, Grant RM. Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS 18:1683–1689, 2004.
- Bohuslav J, Chen L-F, Kwon H, Mu Y, Greene WC. p53 induces NF-kB activation by an IkB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279:26115–26125, 2004.
- Brilot F, Geenen V, Hober D, Stoddart CA. Coxsackievirus B4 infection of human fetal thymus cells J. Virol. 78:9854–9861, 2004.
- Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinksky SM, Zack JA. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science 303:316, 2004.
- Busch R, Cesar D, Higuera-Alhino D, Gee T, Hellerstein MK, McCune JM. Isolation of peripheral blood CD4(+) T cells using RosetteSep and MACS for studies of DNA turnover by deuterium labeling. J. Immunol. Methods 286:97–109, 2004.
- Cavrois M, Neidleman J, Bigos M, Greene WC. Fluorescence resonance energy-based HIV-1 virion fusion assay. In: Flow Cytometry Protocols (Hawley TS, Hawley RG, eds), Humana Press, Totowa, NJ, pp. 333-343, 2004.
- Cavrois M, Neidleman J, Yonemoto W, Fenard D, Greene WC. HIV-1 virion fusion assay: Uncoating not required and no effect of Nef on fusion. Virology. 328:36–44, 2004.
- Chandwani R, Jordan KA, Shacklett BL, Papasavvas E, Montaner LJ, Rosenberg MG, Nixon DF, Sandberg JK. Limited magnitude and breadth in the HLA-A2-restricted CD8 T-cell response to Nef in children with vertically acquired HIV-1 infection. Scand. J. Immunol. 59:109–114, 2004.
- Chen L-f, Greene WC. Shaping the nuclear action of NF-kB. Nat. Rev. Mol. Cell Biol. 5:392–401, 2004.
- Deeks SG, Martin JN, Sinclair E, Harris J, Neilands TB, Maecker HT, Hagos E, Wrin T, Petropoulos CJ, Bredt B, McCune JM. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. J. Infect. Dis. 189:312–321, 2004.
- Friend J, Parkin N, Petropolous C, Chappey C, Liegler T, Martin JN, Deeks SG. Isolated lopiavir resistance after virologic rebound of a ritonavir/lopinavir-based regimen. AIDS 18:1965–1966, 2004.
- Greene WC, Chen L-f. Regulation of NF-kB action by reversible acetylation. In: Reversible Protein Acetylation: Novartis Foundation Symposium No. 259, John Wiley & Sons Ltd., Chichester, UK. 208–222, 2004.
- Greene WC. How resting T cells deMURR HIV infection. Nat. Immunol. 5:18–19, 2004.
- Greene WC. Redistricting the retroviral restriction factors. Nat. Med. 10:770–780, 2004.
- Greene WC. The brightening future of HIV therapeutics. Nat. Immunol. 5:867–871, 2004.
- Gross KL, Porco TC, Grant RM. HIV-1 superinfection and viral diversity. AIDS 18:1513–1520, 2004.
- Heltweg B, Dequiedt F, Marshall BL, Brauch C, Yoshida M, Nishino N, Verdin E, Jung M. Subtype selective substrates for histone deacetylases. J. Med. Chem. 47:5235–5243, 2004.
- Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS 18:981–989, 2004.
- Karlsson RK, Jennes W, Page-Shafer K, Nixon DF, Shacklett BL. Poorly soluble peptides can mimic authentic ELLISPOT responses. J. Immunol. Methods 285:89–92, 2004.
- Kirk GD, de Sanjose S, Ott M. Impact of race on the association between diabetes and HCV. Am. J. Gastroenterol. 99:564, 2004.
- Lee MS, Hanspers K, Barker CS, Korn AP, McCune JM. Gene expression profiles during human CD4+ T cell differentiation. Int. Immunol. 16:1109–1124, 2004.
- Meiklejohn DA, Karlsson RK, Karlsson AC, Chapman JM, Nixon DF, Schweighardt B. ELISPOT cell rescue. J. Immunol. Methods 288:135–147, 2004.
- Neuenburg JK, Sinclair E, Nilsson A, Kreis C, Bacchetti P, Price RW, Grant RM. HIV-producing T cells in cerebrospinal fluid. J. Acquir. Immune Defic. Syndr. 37:1237–1244, 2004.
- North B, Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 5:224, 2004.
- O'Mahony A, Montano M, Van Beneden K, Chen L-F, Greene WC. Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-kB requires IkB kinase-1-mediated phosphorylation of RelA/p65. J. Biol. Chem. 279:18137–18145, 2004.
- Ott M, Dorr A, Hetzer-Egger C, Kaehlcke K, Schnolzer M, Henklein P, Cole P, Zhou MM, Verdin E. Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation. In: Reversible Protein Acetylation: Novartis Foundation Symposium No. 259, John Wiley & Sons Ltd., Chichester, UK. 182–193, 2004.
- Papasavvas E, Kostman JR, Mounzer K, Grant RM, Gross R, Gallo C, Azzoni L, Foulkes A, Thiel B, Pistilli M, Mackiewicz A, Shull J, Montaner LJ. Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection. PLoS Med. 1(3):e64. Epub Dec. 28, 2004.
- Plana M, Garcia F, Oxenius A, Ortiz GM, Lopez A, Cruceta A, Mestre G, Fumero E, Fagard C, Sambeat MA, Segura F, Miro JM, Arnedo M, Lopalcos L, Pumarola T, Hirschel B, Phillips RE, Nixon DF, Gallart T, Gatelll JM. Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm. J. Acquir. Immune Defic. Syndr. 36:791–799, 2004.
- Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, Osmond DH. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18:81–88, 2004.
- Ramsburg E, Rose NF, Marx PA, Mefford M, Nixon DF, Moretto WJ, Montefiori D, Earl P, Moss B, Rose JK. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccina virus Ankara vaccine vectors in a single-boost protocol. J. Virol. 78:3930–3940, 2004.
- Sandberg JK, Stoddart CA, Brilot F, Jordan KA, Nixon DF. Development of innate CD4+ a-chain variable gene segment 24 (Va24) natural killer T cells in the early human fetal thymus is regulated by IL-7. Proc. Natl. Acad. Sci. USA 101:7058–7063, 2004.
- Schaeffer E, Soros VB, Greene WC. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J. Virol. 78:1375–1383, 2004.
- Schweighardt B, Roy AM, Meiklejohn DA, Grace EJ, Moretto WJ, Heymann JJ, Nixon DF. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. J. Virol. 78:9164–9173, 2004.
- Schwer B, Ren S, Kartenbeck J, Kaehlcke K, Pietschmann T, Bartenschlager R, Yen T, Ott M. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J. Virol.78:7958–7968, 2004.
- Segal MR, Barbour JD, Grant RM. Relating HIV-1 sequence variation to replication capacity via trees and forests. Stat. Appl. Genet. Mol. Biol. 3(1):Article 2, 2004. http://www.bepress.com/sagmb/vol3/iss1/art2
- Shacklett BL, Cox CA, Quigley MF, Kreis C, Stollman NH, Jacobson MA, Andersson J, Sandberg JK, Nixon DF. Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection. J. Immunol.173:641–648, 2004.
- Shacklett BL, Cox CA, Wilkens DT, Karlsson KR, Nilsson A, Nixon DF, Price RW. Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J. Inf. Dis. 189:2002–2012, 2004.
- Smith K, Aga E, Bosch RJ, Valdez H, Connick E, Landay A, Kuritzkes D, Gross BH, Francis IR, McCune JM, Kessler H, Lederman M. Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy. AIDS 18:1953–1956, 2004.
- Tsui R, Herring BL, Barbour JD, Grant RM, Bacchetti P, Kral A, Edlin BR, Delwart EL. Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure. J. Virol.78:94–103, 2004.
- Verdin E, Dequiedt F, Fischle W, Frye R, Marshall B, North B. Measurement of mammalian histone deacetylase activity. Methods Enzymol.377:180–196, 2004.
- Verdin E, Dequiedt F, Kasler H. HDAC7 regulates apoptosis in developing thymocytes. In: Reversible Protein Acetylation: Novartis Foundation Symposium No. 259, John Wiley & Sons Ltd., Chichester, UK. 115–131, 2004.
- Waltregny D, de Leval L, Glénisson W, Tran SL, North BJ, Bellahcène A, Weidle U, Verdin E, Castronovo V. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. Am. J. Pathol. 165:553–564, 2004.
- Waltregny D, North B, Van Mellaert F, de Leval J, Verdin E, Castronovo V. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells. Eur. J. Histochem. 48:273–290, 2004.
- Williams SA, Chen L-F, Kwon H, Fenard D, Bisgrove D, Verdin E, Greene WC. Prostratin antagonizes HIV latency by activating NF-kB. J. Biol. Chem. 279:42008–42017, 2004.
- Witte V, Laffert B, Rosorius O, Lischka P, Blume K, Galler G, Stilper A, Willbold D, D'Aloja P, Sixt M, Kolanus J, Ott M, Kolanus W, Schuler G, Baur A. HIV-1 Nef mimics and integrin receptor signal that recruits the polycomb group protein eed to the plasma membrane. Mol. Cell 13:179–190, 2004.
|
|
|
|
|
|
